FEATURE ARTICLES
Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.
- Minimizing The Impact Of Human Errors Using Relational Risk Analysis
- Trends And Benefits Of Lean Manufacturing In Pharmaceutical Injectable Facilities
- Environmental Monitoring Performance Qualification In New Drug Manufacturing Facilities
- The Rise Of NAMs
- FDA Priority Voucher Program Submissions Window Opens On New Website
- Outsourced, In-House, Or A Combo: An Agile Recruiting Strategy Fuels Growth In Pharmas And Biotechs
- 5 Best Practices For Improving AI Literacy In A GxP Environment
PHARMA ONLINE WHITE PAPERS
-
![Artificial Intelligence IDEA, AI light Bulb Idea-GettyImages-2164746643]( "The Impact Of Artificial Intelligence On CQV")
The Impact Of Artificial Intelligence On CQVAI is revolutionizing CQV in life sciences by automating documentation, enabling real-time monitoring, and driving predictive quality to boost efficiency and compliance across validation processes.
-
Enabling CDMOs To Focus On Core Priorities4/26/2024
Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.
-
Enabling Digital Twins With Computational Fluid Dynamics Modeling1/16/2025
Embrace the transformative power of predictive modeling and digital twin technology to optimize bioprocess efficiency, ensure product quality, and drive innovation in biopharmaceutical manufacturing.
-
Combining Digital Platforms And QbD Principles7/9/2024
How can data and digitalization further improve pharmaceutical development and the continuous, quick, and efficient delivery of products?
-
Nitrosamine Analysis: Solutions For Risk Management And Analytical Testing8/22/2024
Testing for nitrosamines is essential in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and drug products to ensure safety and compliance.
-
A Scalable Single-Use Two-Step pDNA Purification Process3/6/2024
Evaluate the performance of a single-use two-step plasmid purification process, and see how it compares to the existing three-step purification method.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Part 1: Intuitive Bioprocess Scale-Up From Bench Scale To Pilot Scale
- Matrigel Dome Assay And Drug Screening Of Colorectal Cancer Organoids
- Highly Sensitive ELISAs In 90 Minutes
- LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting
- Designing Protocols For A 40% Emulsifiable Concentrate Of A Systemic Insecticide
NEWSLETTER ARCHIVE
- 08.09.25 -- Pharmaceutical Online Best Of July
- 08.09.25 -- Proven Products And Services For Oral Solid Dose Manufacturing
- 08.08.25 -- Pharmaceutical Product Inspection Solutions
- 08.07.25 -- Looking For Help With Your Pharmaceutical Facility Design Project?
- 08.07.25 -- STREAM Edition: Accelerating Construction With Modular Facility Design
INDUSTRY NEWS
-
![expensive healthcare, drug container, pills-GettyImages-171587042]( "President Trump Demands MFN Prices In Manufacturer Letters")
President Trump Demands MFN Prices In Manufacturer LettersPresident Trump has sent out a letter to 17 major pharmaceutical manufacturers, asking them to commit to lower prices by Sept. 29, 2025, or he plans to deploy every tool in his arsenal to protect American families.
-
![Bristol Myers Squibb office-GettyImages-2160008492]( "Bristol Myers Squibb Forms Immunology Company With Finance Partner")
Bristol Myers Squibb Forms Immunology Company With Finance PartnerThe NewCo pipeline will start with three clinical-stage and two phase 1-ready investigational medicines that each target mechanisms in autoimmune diseases.
-
![GettyImages-2139576234-partner-team-collaborate-collaboration-meet]( "George Tidmarsh Named CDER Director")
George Tidmarsh Named CDER DirectorTidmarsh has over 30 years of experience in biotechnology, clinical medicine, and regulatory science and has authored 143 scientific publications and patents.
-
![GettyImages-1125144281-sanofi]( "Sanofi Expands Immunology Portfolio With Blueprint Acquisition")
Sanofi Expands Immunology Portfolio With Blueprint AcquisitionSanofi expanded its portfolio in immunology with the completed acquisition of Blueprint Medicines Corporation.
-
![FDA Approved GettyImages-1215516118]( "FDA Publishes 200+ CRLs For Increased Transparency")
FDA Publishes 200+ CRLs For Increased TransparencyThe letters were made available to increase transparency and help sponsors reduce similar mistakes in the future.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
The modern microbiology laboratory is starting to look very different from the laboratory of even 10 years ago. The work will be similar, yet technology will have advanced. Automation, in particular, is taking center stage. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Meissner Announces New Rotary Impeller Mixing Solutions (RMS) Portfolio To Elevate Biocontainer Mixing Performance8/11/2025
Meissner is proud to announce the launch of its RMS (Rotary Impeller Mixing Solutions) portfolio, engineered to redefine reliability and performance in biocontainer mixing for bioprocessing. This innovative product line addresses the growing demand among biomanufacturers for robust, highquality mixing with the added assurance of supply chain security and dependable partnership.
-
IMA Group To Exhibit Pharma Packaging Equipment At Pack Expo 20258/7/2025
Visitors will have the chance to meet the experts from the IMA Group, world leader in the design and manufacture of automatic processing and packaging machines, that will be presenting their latest technologies and developments.
-
Garonit Pharmaceutical To Establish New Manufacturing Facility In Upstate NY8/7/2025
Governor Kathy Hochul today announced that Garonit Pharmaceutical, Inc., a global manufacturer of antiseptic products and health care solutions, will establish a state-of-the-art, 200,000-square-foot pharmaceutical manufacturing facility in New Windsor, Orange County.
-
CDMO Bora Pharmaceuticals Procures Gerteis Roller Compactor For Minnesota Drug Manufacturing Facility Expansion8/6/2025
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a global leader in pharmaceutical manufacturing, has announced plans for significant investments to expand its manufacturing and packaging capabilities at its facility in Maple Grove, Minnesota. This is a major upgrade to the site, which Bora acquired in 2024 as part of its $210 million acquisition of Upsher-Smith Laboratories, expanding its U.S. manufacturing footprint.
-
CDMO Eramol To Open New Sterile Manufacturing In UK Early 20268/4/2025
Eramol, a UK-based pharmaceutical contract development and manufacturing organisation (CDMO), is pleased to announce significant progress on its new state-of-the-art sterile manufacturing facility, scheduled to open in early 2026.
